XTLB   $1.88  7.43% Market Closed

X T L Biopharmaceuticals Ltd
Total Cash 2.34M
totalCashPerShare 0.004
EBITDA
Total Debt 0.00
quickRatio 10.489
currentRatio 11.426
Total Revenue
debtToEquity
Revenue/Share
ROA -0.1378
ROE -0.13066
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 989.39M
forwardPE
floatShares 487.72M
sharesOutstanding 5.45M
sharesShort 14.67K
sharesShortPriorMonth 9.70K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.02%
Short Ratio help_outline 1.44%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.005
Price To Book help_outline 364.00
earningsQuarterlyGrowth
netIncomeToCommon -378.00K
trailingEps -0.03%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 5
lastUpdated Nov. 6, 2024, 5:26 p.m.